Zhenyi Jiang
Managing Associate
Zhenyi Jiang advises clients on transactions involving mergers and acquisitions (M&A), private equity, and venture capital. She represents funds and corporations making investments in the ecommerce, life sciences, healthcare, and technology industries, among others. Zhenyi is fluent in Mandarin and English.
- Represented Silk Road Fund, a sovereign investment fund, in its participation in a BlackRock& Hassana, a lead global investor consortium, acquisition of a 49% stake in Aramco Gas Pipelines Company from Saudi Arabian Oil Co. for $15.5 billion
- Represented GIC in its investment in connection with the Series Pre-C round financing of Alebund, a clinical-stage biopharmaceutical company
- Represented B Capital in its investment in connection with the Series A+ round financing of AlphaPrime Life Sciences, a company engaged in the business of technology platforms and services in the life sciences and healthcare industries
- Represented Lake Bleu Capital in its investment in connection with the Series B found financing of Singleron Biotechnologies, an innovative molecular diagnostic company
- New York University School of Law, 2020, LL.M., Corporation Law
- Peking University Law School, China, 2013, LL.M., International Law
- Peking University, China, 2011, B.A., Law and Economics (Double Major)
- People's Republic of China (Qualified)
- New York
Recipient, Dean’s Graduate Award, New York University School of Law
Recipient, Wang Tieya Scholarship, Peking University
Recipient, Guanghua Scholarship, Peking University